Overexpression of Apobec3f in Tumor Tissues is Potentially Predictive for Poor Recurrence-Free Survival from Hbv-Related Hepatocellular Carcinoma

Zongguo Yang,Liping Zhuang,Yuan Yu,Weili Zhou,Yunfei Lu,Qingnian Xu,Bozong Tang,Xiaorong Chen

2015-01-01

Discovery medicine

Abstract:The relationship between members of APOBEC3 in tumor tissues and hepatocellular carcinoma prognosis was not well studied. We compared APOBEC3 expression between tumor and non-tumor tissues based on the expression profile GSE14520 from Gene Expression Omnibus (GEO), and correlated APOBEC3 in tumor tissues with outcomes of HCC patients. APOBEC3B, which was significantly up-regulated in HCC tumor tissues (P < 0.001), was negatively associated with HCC overall survival by Cox regression (HR=1.005, 95% CI=1.0-1.009, P=0.033). However, no significant difference was found of APOBEC3B and HCC overall survival by Kaplan-Meier method. HCC patients with high APOBEC3F expression in tumor tissues more likely coexist with multinodular tumors than those with low APOBEC3F level (26.4% and 13.6%, respectively, P=0.018). Cox univariate and multivariate regression analyses revealed that APOBEC3F overexpression in tumor tissues was negatively associated with HCC recurrence (HR=1.132, 95% CI=1.013-1.265, P=0.028). Additionally, the higher the APOBEC3F expressed, the greater risk of poor recurrence-free survival for HCC patients (mean survival time high=32.25 and low=42.68 months, respectively; log rank P=0.012) when grouped by lower quartile cut-off of 10.98. Conclusions: Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from HBV-HCC patients. The role of other APOBEC3 members in HCC development needed further research.